The message reiterated an offer for a chance to take a second job or travel to a “dream destination” and remain on the ...

The map of flu activity across the United States continues to darken, both figuratively and literally, as case numbers spike upward in most states, according to the Centers for Disease Control and ...

New poll shows about half of U.S. adults believe it is a good thing for adults to use weight-loss drugs if they are ...

The killings of a Border Patrol agent in Vermont last week, a state’s witness in California, and a pair of senior citizens in ...

Across the country, dairy producers have dumped milk and infected chickens have been killed, including millions of egg-laying ...

The University at Buffalo School of Dental Medicine is partnering with the SUNY Erie Dental Hygiene program to offer free ...

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

The man who hopes to be President Donald Trump’s health secretary repeatedly asked to see “data” or “science” showing ...

Experts dive into the new report of harmful metal levels in protein powders and what parents can do. What To Know About Lead ...

ADA expresses concern over Trump administration's pause on federal assistance programs, citing potential risks to oral health initiatives and dental industry.

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval is an ...